ALB vs EBS · $8.00B cap vs rev $1.04B
Albemarle Corp (ALB) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
ALB does not have a complete income-statement cache yet.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
ALB currently screens at market cap $8.00B. EBS currently screens at market cap $416.4M.
Not investment advice. Open the ALB and EBS stock pages for the full models.
Not investment advice.